ID   GFP-CD16-V/V.NK-92
AC   CVCL_W734
DR   ATCC; PTA-8836
DR   Wikidata; Q54835740
RX   Patent=US9181322;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8836.
CC   Transfected with: HGNC; 3619; FCGR3A (with p.Phe176Val).
CC   Transfected with: UniProtKB; P42212; GFP.
CC   Derived from sampling site: Peripheral blood. Cell type=Natural killer cell.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 16-12-21; Version: 9
//
RX   Patent=US9181322;
RA   Campbell K.S.;
RT   "Genetically modified human natural killer cell lines.";
RL   Patent number US9181322, 10-Nov-2015.
//